Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban with Endovascular Therapy for Intracranial Atherosclerotic Stroke
NCT07026318Recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Aug 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in ischemic stroke comparing Tirofiban Group with Placebo Group (2 arms). Primary endpoints: Proportion of patients with modified Rankin Scale 0-2 at 90 days and Probability of symptomatic intracranial hemorrhage at 48 hours. Started Aug 2025; status: recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07026318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07026318.